Drug Side Effects
Search
OROPHARYNGEAL CANCER RECURRENT
OROPHARYNGEAL CANCER RECURRENT
was reported 6 times
These drug classes are most commonly taken by patients reporting OROPHARYNGEAL CANCER RECURRENT:
#
Drug
Count
0
CD20-directed Cytolytic Antibody [EPC]
1
1
Epidermal Growth Factor Receptor Antagonist [EPC]
1
2
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
3
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
4
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
5
Interleukin-4 Receptor alpha Antagonist [EPC]
1
6
Nucleoside Metabolic Inhibitor [EPC]
1
7
Opioid Agonist [EPC]
1
8
Platinum-based Drug [EPC]
1